Decentralized Clinical Trials Market

Decentralized clinical trials (DCTs) offer a more patient-centric approach, reflecting a transformational philosophy for the conduct of clinical trials in which fewer clinic visits are required and patient and caregiver burden is reduced. To achieve this, DCTs deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patient?s own home.

The specific digital technologies used for data collection vary by study but can include telemedicine, wearable/sensor devices, eConsent, electronic clinical outcome assessments (eCOA), and electronic health (eHealth) records. Mobile technologies are often used to replace written diaries with electronic diaries and to collect data from wearable sensor devices. In-home services allow the collection of vitals such as blood pressure and blood samples.

Decentralized Clinical Trials Market contains market size and forecasts of Decentralized Clinical Trials (DCTs) in Global, including the following market information:

Global Decentralized Clinical Trials (DCTs) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Decentralized Clinical Trials (DCTs) market was valued at 7341.6 million in 2021 and is projected to reach US$ 18560 million by 2028, at a CAGR of 14.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Interventional Trials Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Decentralized Clinical Trials (DCTs) include ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle and CRF Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Decentralized Clinical Trials (DCTs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Decentralized Clinical Trials (DCTs) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Type, 2021 (%)

Interventional Trials

Observational Trials

Expanded Access Trials

Global Decentralized Clinical Trials (DCTs) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, by Application, 2021 (%)

Oncology

Cardiovascular Disease

Others

Global Decentralized Clinical Trials (DCTs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Decentralized Clinical Trials (DCTs) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Decentralized Clinical Trials (DCTs) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Decentralized Clinical Trials (DCTs) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

ICON Plc

LEO Innovation Lab

Science 37

PRA Health Sciences

Clinical Ink

Parexel

Medable

Oracle

CRF Health

Medidata

Covance

IQVIA

PPD

PWNHealth, LLC

Medrio